$6.28
0.427.17%
At close: -
$6.28
0.000.00%
After Hours: Dec 20, 4:02 PM EDT
Enanta Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Enanta Pharma using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-25 | $-1.36 | $-1.41 | 3.55 % |
Jun 2024 | 2024-08-05 | $-1.07 | $-1.45 | 26.2 % |
Mar 2024 | 2024-05-06 | $-1.47 | $-1.33 | -10.5 % |
Dec 2023 | 2024-02-07 | $-1.58 | $-1.19 | -32.8 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-25 | $14.61M | $16.07M | -9.10 % |
Jun 2024 | 2024-08-05 | $17.97M | $17.18M | 4.60 % |
Mar 2024 | 2024-05-06 | $17.05M | $16.52M | 3.23 % |
Dec 2023 | 2024-02-07 | $18.00M | $21.28M | -15.4 % |
Enanta Pharma (ENTA) is scheduled to report earnings on February 5, 2025. The last reported earnings were for reported on November 25, 2024 for Q4.
The Actual EPS was $-1.36, which beat the estimate of $-1.41.
The Actual Revenue was $14.6M, which missed the estimate of $16.1M.
Browse earnings estimates, EPS, and revenue on all stocks.